Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaello Ditaranto

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 30, 2025
Patterns of Left Ventricular Remodeling and Outcomes in Fabry DiseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
European Heart Journal. Cardiovascular Imaging|September 25, 2025
Sex-specific prognostic thresholds of left ventricular hypertrophy in Fabry diseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
Journal of the American Heart Association|May 23, 2025
Evolution of Cardiac Damage Staged With Echocardiography in Fabry DiseaseRosa Lillo, Maria Chiara Meucci, Annamaria Del Franco, et al.
Cell Death & Disease|December 13, 2021
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry diseaseIrene Salamon, Elena Biagini, Paolo Kunderfranco, et al.
JACC. Cardiovascular Imaging|August 5, 2023
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry DiseaseRaffaello Ditaranto, Ornella Leone, Luigi Lovato, et al.
Open Heart|April 21, 2022
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathyMaddalena Graziosi, Raffaello Ditaranto, Claudio Rapezzi, et al.
International Journal of Cardiology|January 19, 2024
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypesBeatrice Musumeci, Giacomo Tini, Elena Biagini, et al.
European Heart Journal. Cardiovascular Imaging|October 28, 2025
Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance StudyPietro Francia, Giulio Falasconi, Maria Beatrice Musumeci, et al.
Heart (British Cardiac Society)|February 10, 2021
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathyGiovanni Vitale, Raffaello Ditaranto, Francesca Graziani, et al.
International Journal of Cardiology|March 31, 2025
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progressionVanda Parisi, Raffaello Ditaranto, Nevio Taglieri, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 30, 2025
Patterns of Left Ventricular Remodeling and Outcomes in Fabry DiseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
European Heart Journal. Cardiovascular Imaging|September 25, 2025
Sex-specific prognostic thresholds of left ventricular hypertrophy in Fabry diseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
Journal of the American Heart Association|May 23, 2025
Evolution of Cardiac Damage Staged With Echocardiography in Fabry DiseaseRosa Lillo, Maria Chiara Meucci, Annamaria Del Franco, et al.
Cell Death & Disease|December 13, 2021
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry diseaseIrene Salamon, Elena Biagini, Paolo Kunderfranco, et al.
JACC. Cardiovascular Imaging|August 5, 2023
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry DiseaseRaffaello Ditaranto, Ornella Leone, Luigi Lovato, et al.
Open Heart|April 21, 2022
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathyMaddalena Graziosi, Raffaello Ditaranto, Claudio Rapezzi, et al.
International Journal of Cardiology|January 19, 2024
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypesBeatrice Musumeci, Giacomo Tini, Elena Biagini, et al.
European Heart Journal. Cardiovascular Imaging|October 28, 2025
Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance StudyPietro Francia, Giulio Falasconi, Maria Beatrice Musumeci, et al.
Heart (British Cardiac Society)|February 10, 2021
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathyGiovanni Vitale, Raffaello Ditaranto, Francesca Graziani, et al.
International Journal of Cardiology|March 31, 2025
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progressionVanda Parisi, Raffaello Ditaranto, Nevio Taglieri, et al.
Pageof 4